Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Day One Biopharmaceuticals
Day One Biopharmaceuticals
Ipsen builds again, licensing Day One glioma drug
Pharmaphorum
Thu, 07/25/24 - 11:10 am
Ipsen
glioma
brain cancer
Day One Biopharmaceuticals
Ojemda
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
Fierce Biotech
Tue, 06/18/24 - 11:45 am
Day One Biopharmaceuticals
MabCare Therapeutics
solid tumors
antibody-drug conjugate
DAY301
Day One’s Ojemda Gets FDA Accelerated Approval for Pediatric Brain Tumor
BioSpace
Wed, 04/24/24 - 08:46 am
Day One Biopharmaceuticals
FDA
tovorafenib
Ojemda
pediatric
brain tumors
pediatric low-grade glioma
Two days after showing strong pediatric cancer data, Day One taps $150M in public capital
Endpoints
Wed, 06/15/22 - 10:54 am
Day One Biopharmaceuticals
funding
tovorafenib
pediatric cancer
brain cancer
A new day for pediatric cancer patients: Day One's share price doubles on initial data for brain tumor drug
Fierce Biotech
Mon, 06/13/22 - 09:56 pm
Day One Biopharmaceuticals
tovorafenib
pediatric
pediatric cancer
brain cancer
pediatric low-grade glioma
Merck KGaA offloads clinical-phase cancer drugs to Day One
Fierce Biotech
Tue, 02/23/21 - 10:45 am
Merck KGaA
Day One Biopharmaceuticals
pimasertib
solid tumors
